

Yatharth Hospital IPO



Yatharth Hospital bucked the recent trend of strong listings by debuting at a mild premium of just 2% over the issue price on Monday.
The weak listing, which was well below expectations, was mainly due to the ongoing uncertainty in the markets. However, post the listing, the stock rallied to a high of Rs 342, up nearly 14% over the IPO price of Rs 300.
Analysts advised investors to book profits at this level, suggesting that those with a long-term view can hold the stock.
"Investors who are looking for short-term gains may book profits at this level. However, aggressive investors who believe in the long-term prospects of the company may hold the stock with a stop loss at around the issue price," said Anubhuti Mishra, Equity Research Analyst at Swastika Investmart.
Investors who are looking for short-term gains may book profits at this level. However, aggressive investors who believe in the long-term prospects of the company may hold the stock with a stop loss at around the issue price, she advised.
Read more at:
- Yatharth Hospital misses Street expectations on listing. What should investors do now? - The Economic Times
- Yatharth Hospital share price gains after dismal listing. Buy, sell or hold? - Mint
- Yatharth Hospital shares deliver mild gains on debut; stock lists at 2% premium - CNBC TV18
- Yatharth Hospital shares close with 11% premium on debut - Money Control
- Yatharth Hospital’s Trading Strategy: Falling Short of Market Expectations on Listing – Guidance for Investors. - Verve Times
- Yatharth Hospital Shares Debut At Muted Premium Of 2% Over IPO Price - Outlook
- Yatharth Hospital Shares Make a Flat Debut On D-St; Lists At 2% Premium At Rs 306.10 - News18
- Yatharth Hospital shares deliver mild gains on debut; stock lists at 2% premium - MSN
- Yatharth Hospital misses Street expectations on listing. What should investors do now? - MSN
- Yatharth Hospital shares: After a disappointing debut a D-St; is it time to buy the debutant? - MSN
